Abstract:Background: Paclitaxel is a natural anticancer drug, which has demonstrated significant activity in clinical trials. However, it has been limited due to poor aqueous solubility. Chitosan can be modified into graft copolymer, which changed into nanoparticles in aqueous solution, and employed as controlled release carriers for drugs. Objective: To study the characterization, in addition, to evaluate in vitro drug release ability of paclitaxel nanoparticles. Design, time and setting: A repeated measurement design was conducted at the Laboratory of North China Coal Medical University from January 2008 to July 2008. Materials: The average molecular weight of 2.0 × 10 5 chitosan with 92% deacetylation degree was produced by Golden-shell Biochemical Co., Ltd. Paclitaxel (lot number: 082329802) was provided by National Institute for the Control of Pharmaceutical and Biological Products. Methods: The potassium diperiodaton-ickelate served as initiator, chitosan-graft-vinyl acetate copolymers were synthesized by free radical graft copolymerization, which could be directly transformed into nanoparticles with hydrophobic core and hydrophilic surface in the water medium. Paclitaxel nanopartioles were prepared via mixture 0.5-5.0 mg paclitaxel with nanoparticles by ultrasonic irradiation technology. Main outcome measures: Particles size, polydispersity index zeta potential was detected by laser particle size analyzer. The morphology of chitosan nanoparticles and paclitaxel nanoparticles was observed by transmission electron microscope. In addition, encapsulation capability, loading content and in vitro drug release of the paclitaxel nanoparticles was analyzed by high-performance liquid chromatography. Results: The mean diameters of chitosan nanoparticles and paclitaxel nanoparticles were 196.2 nm and 320.8 nm, respectively. The nanoparticles possessed a uniform particles size distribution and an obvious positive charge surface, but the Zeta potential had no significant difference (F=0.818, F=3.38, all P > 0.05). The dose of paclitaxel could affect the encapsulation rate, which could up to 93.6% when added the quantity of paclitaxel was 2% of anoparticles. The results of simulate drug release showed that drug release was reach 48.3% in 24 hours at the burst release phase, which up to 75.9% at 175 hours longer in the slower release phase. The encapsulation rate of drug-loaded nanoparticles was stable. Conclusion: The preparation method is reliable and simple. The nanoparticles possessed good physical performance and sustained release character in vitro.

Preparation of paclitaxel-loaded mixed micelles and enhancement on oral absorption of paclitaxel

Preparation of Paclitaxel-loaded Mixed Micelles and Its in Situ Absorption in Rat Intestine

Preparation and in vitro evaluation of paclitaxel-loaded mixed micelles

Stable Phosphatidylcholine-Bile Salt Mixed Micelles Enhance Oral Absorption of Paclitaxel: Preparation and Mechanism in Rats

Preparation and Characterization of PEGylated Paclitaxel Liposomes

Improved oral absorption and anti-lung cancer activity of paclitaxel-loaded mixed micelles

Polymeric Micelles Based on Modified Glycol Chitosan for Paclitaxel Delivery: Preparation, Characterization and Evaluation

Enhanced Oral Bioavailability of Paclitaxel in Pluronic/lhr Mixed Polymeric Micelles: Preparation, in Vitro and in Vivo Evaluation

Preparation and Evaluation in Vitro and in Vivo of Docetaxel Loaded Mixed Micelles for Oral Administration.

Improved intestinal absorption of paclitaxel by mixed micelles self-assembled from vitamin E succinate-based amphiphilic polymers and their transcellular transport mechanism and intracellular trafficking routes.

Preparation of Paclitaxd Liposomes Modified with Mpeg-Dspe and Its Pharmacokinetics in Rats

Enhanced Oral Bioavailability of Paclitaxel Formulated in Vitamin E-TPGS Emulsified Nanoparticles of Biodegradable Polymers: in Vitro and in Vivo Studies

Enhanced Oral Absorption of Paclitaxel in N-Deoxycholic Acid-N, O-Hydroxyethyl Chitosan Micellar System

Phospholipid-Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxel.

Pluronic-poly (acrylic acid)-cysteine/Pluronic L121 mixed micelles improve the oral bioavailability of paclitaxel

Pharmacokinetics and biodistribution of paclitaxel-loaded pluronic P105/L101 mixed polymeric micelles.

Multi-functional Chitosan Polymeric Micelles for improving the oral bioavailability of Paclitaxel based on synergistic effect

Enhanced Oral Delivery Of Paclitaxel Using Acetylcysteine Functionalized Chitosan-Vitamin E Succinate Nanomicelles Based On A Mucus Bioadhesion And Penetration Mechanism

Enhancement on Oral Absorption of Paclitaxel by Multifunctional Pluronic Micelles.

Study on the Preparation of Paclitaxel-Loaded Pluronic Stabilized Micellae

Preparation, characterization and drug release property of paclitaxel nanoparticles